PWAM
IRWD icon

Private Wealth Asset Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

Private Wealth Asset Management’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$25.3K Hold
6,000
– – ﹤0.01% 530
2026
Q1 		$21.1K Buy
+6,000
New +$24.6K ﹤0.01% 552
2025
Q2 		– Sell
-209
Closed -$307 – 1174
2025
Q1 		$307 Buy
+209
New +$498 ﹤0.01% 1027

Other funds holding IRWD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Private Wealth Asset Management's IRWD Position: Q2 2026 in Review

Private Wealth Asset Management held its Ironwood Pharmaceuticals (IRWD) position steady in Q2 2026 at 6,000 shares worth $25.3K. The position accounts for ﹤0.01% of the portfolio, ranked #530.

Private Wealth Asset Management first reported a position in IRWD in Q1 2025 and has held it in 3 quarters since. 212 funds tracked by Wall St. Rank hold IRWD as of Q2 2026.

  • Private Wealth Asset Management held 6,000 shares of Ironwood Pharmaceuticals worth $25.3K as of Q2 2026.
  • Private Wealth Asset Management left its Ironwood Pharmaceuticals share count unchanged in Q2 2026.
  • Ironwood Pharmaceuticals made up ﹤0.01% of Private Wealth Asset Management's portfolio in Q2 2026, its #530 holding.
  • Private Wealth Asset Management first reported a position in Ironwood Pharmaceuticals in Q1 2025 and has held it in 3 quarters since.
  • 212 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2026.

Based on Private Wealth Asset Management's 13F filing for Q2 2026, filed 11 Aug 2026.